神経刺激機器の世界市場2023~2027

■ 英語タイトル:Global Neurostimulation Devices Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR70270-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR70270-23
■ 発行日:2023年8月21日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医療機器
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥355,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥568,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[神経刺激機器の世界市場2023~2027]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

世界の神経刺激機器市場 2023-2027
神経刺激機器市場は2022-2027年に6,257.05百万米ドルで成長し、予測期間中のCAGRは12.19%で加速すると予測されています。
この調査レポートは、神経刺激機器市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の有病率の上昇、神経医療に対する認識とアクセスを向上させる取り組みの増加、高齢者人口の急激な増加などが市場を牽引しています。

Technavioの神経刺激機器市場は以下のように区分されます:

用途別:
- 疼痛管理
- 尿失禁・便失禁
- パーキンソン病
- てんかん
- その他

製品別:
- 埋め込み型神経刺激機器
- 体外式神経刺激機器

地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、神経刺激機器の適応症の拡大が、今後数年間の神経刺激機器市場の成長を促進する主要な理由の1つであると特定しています。また、神経刺激技術に関連する研究を支援するイニシアチブの増加や神経刺激機器の技術的進歩は、市場の大きな需要につながるでしょう。

神経刺激機器市場に関するレポートは以下の分野をカバーしています:
- 神経刺激機器市場のサイジング
- 神経刺激機器市場予測
- 神経刺激機器市場の産業分析

本レポートでは、神経刺激機器市場の主要ベンダーには、Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Axonics Inc., Bayer AG, Bioinduction Ltd, Boston Scientific Corp., electroCore Inc., EndoStim Inc, Integer Holdings Corp., LABORIE MEDICAL TECHNOLOGIES CORP., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Parasym, Perflow Medical Ltd., Soterix Medical Inc., and Synapse Biomedical Incなどが含まれます。また、神経刺激機器市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.過去の市場規模
5.ファイブフォース分析
6.神経刺激機器市場のセグメンテーション:用途別
7.神経刺激機器市場のセグメンテーション:製品別
8.顧客状況
9.地理的状況
10.推進要因・課題・傾向
11.企業状況
12.企業分析
13.付録

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global neurostimulation devices market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global neurostimulation devices market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Pain management – Market size and forecast 2022-2027
o Exhibit 34: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Pain management – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
o 6.4 Urinary and fecal incontinence – Market size and forecast 2022-2027
o Exhibit 38: Chart on Urinary and fecal incontinence – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Urinary and fecal incontinence – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Urinary and fecal incontinence – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Urinary and fecal incontinence – Year-over-year growth 2022-2027 (%)
o 6.5 Parkinsons disease – Market size and forecast 2022-2027
o Exhibit 42: Chart on Parkinsons disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Parkinsons disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Parkinsons disease – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Parkinsons disease – Year-over-year growth 2022-2027 (%)
o 6.6 Epilepsy – Market size and forecast 2022-2027
o Exhibit 46: Chart on Epilepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Epilepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Epilepsy – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Epilepsy – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ million)
o Exhibit 55: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 56: Chart on Product – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 58: Chart on Comparison by Product
o Exhibit 59: Data Table on Comparison by Product
o 7.3 Implantable neurostimulation devices – Market size and forecast 2022-2027
o Exhibit 60: Chart on Implantable neurostimulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Implantable neurostimulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Implantable neurostimulation devices – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Implantable neurostimulation devices – Year-over-year growth 2022-2027 (%)
o 7.4 External neurostimulation devices – Market size and forecast 2022-2027
o Exhibit 64: Chart on External neurostimulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on External neurostimulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on External neurostimulation devices – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on External neurostimulation devices – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 68: Market opportunity by Product ($ million)
o Exhibit 69: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 107: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories – Overview
o Exhibit 120: Abbott Laboratories – Business segments
o Exhibit 121: Abbott Laboratories – Key news
o Exhibit 122: Abbott Laboratories – Key offerings
o Exhibit 123: Abbott Laboratories – Segment focus
o 12.4 ALEVA NEUROTHERAPEUTICS SA
o Exhibit 124: ALEVA NEUROTHERAPEUTICS SA – Overview
o Exhibit 125: ALEVA NEUROTHERAPEUTICS SA – Product / Service
o Exhibit 126: ALEVA NEUROTHERAPEUTICS SA – Key offerings
o 12.5 Bayer AG
o Exhibit 127: Bayer AG – Overview
o Exhibit 128: Bayer AG – Business segments
o Exhibit 129: Bayer AG – Key news
o Exhibit 130: Bayer AG – Key offerings
o Exhibit 131: Bayer AG – Segment focus
o 12.6 Boston Scientific Corp.
o Exhibit 132: Boston Scientific Corp. – Overview
o Exhibit 133: Boston Scientific Corp. – Business segments
o Exhibit 134: Boston Scientific Corp. – Key news
o Exhibit 135: Boston Scientific Corp. – Key offerings
o Exhibit 136: Boston Scientific Corp. – Segment focus
o 12.7 electroCore Inc.
o Exhibit 137: electroCore Inc. – Overview
o Exhibit 138: electroCore Inc. – Product / Service
o Exhibit 139: electroCore Inc. – Key offerings
o 12.8 EndoStim Inc
o Exhibit 140: EndoStim Inc – Overview
o Exhibit 141: EndoStim Inc – Product / Service
o Exhibit 142: EndoStim Inc – Key offerings
o 12.9 LABORIE MEDICAL TECHNOLOGIES CORP.
o Exhibit 143: LABORIE MEDICAL TECHNOLOGIES CORP. – Overview
o Exhibit 144: LABORIE MEDICAL TECHNOLOGIES CORP. – Product / Service
o Exhibit 145: LABORIE MEDICAL TECHNOLOGIES CORP. – Key offerings
o 12.10 LivaNova Plc
o Exhibit 146: LivaNova Plc – Overview
o Exhibit 147: LivaNova Plc – Business segments
o Exhibit 148: LivaNova Plc – Key offerings
o Exhibit 149: LivaNova Plc – Segment focus
o 12.11 Medtronic Plc
o Exhibit 150: Medtronic Plc – Overview
o Exhibit 151: Medtronic Plc – Business segments
o Exhibit 152: Medtronic Plc – Key news
o Exhibit 153: Medtronic Plc – Key offerings
o Exhibit 154: Medtronic Plc – Segment focus
o 12.12 NeuroMetrix Inc.
o Exhibit 155: NeuroMetrix Inc. – Overview
o Exhibit 156: NeuroMetrix Inc. – Product / Service
o Exhibit 157: NeuroMetrix Inc. – Key offerings
o 12.13 NEURONETICS Inc.
o Exhibit 158: NEURONETICS Inc. – Overview
o Exhibit 159: NEURONETICS Inc. – Product / Service
o Exhibit 160: NEURONETICS Inc. – Key offerings
o 12.14 NeuroPace Inc.
o Exhibit 161: NeuroPace Inc. – Overview
o Exhibit 162: NeuroPace Inc. – Product / Service
o Exhibit 163: NeuroPace Inc. – Key offerings
o 12.15 Nevro Corp.
o Exhibit 164: Nevro Corp. – Overview
o Exhibit 165: Nevro Corp. – Product / Service
o Exhibit 166: Nevro Corp. – Key offerings
o 12.16 Soterix Medical Inc.
o Exhibit 167: Soterix Medical Inc. – Overview
o Exhibit 168: Soterix Medical Inc. – Product / Service
o Exhibit 169: Soterix Medical Inc. – Key offerings
o 12.17 Synapse Biomedical Inc.
o Exhibit 170: Synapse Biomedical Inc. – Overview
o Exhibit 171: Synapse Biomedical Inc. – Product / Service
o Exhibit 172: Synapse Biomedical Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global neurostimulation devices market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Urinary and fecal incontinence – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Urinary and fecal incontinence – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Urinary and fecal incontinence – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Urinary and fecal incontinence – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Parkinsons disease – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Parkinsons disease – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Parkinsons disease – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Parkinsons disease – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Epilepsy – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Epilepsy – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Epilepsy – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Epilepsy – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Data Table on Market opportunity by Application ($ million)
Exhibits56: Chart on Product – Market share 2022-2027 (%)
Exhibits57: Data Table on Product – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Product
Exhibits59: Data Table on Comparison by Product
Exhibits60: Chart on Implantable neurostimulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Implantable neurostimulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Implantable neurostimulation devices – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Implantable neurostimulation devices – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on External neurostimulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on External neurostimulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on External neurostimulation devices – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on External neurostimulation devices – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Product ($ million)
Exhibits69: Data Table on Market opportunity by Product ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories – Overview
Exhibits120: Abbott Laboratories – Business segments
Exhibits121: Abbott Laboratories – Key news
Exhibits122: Abbott Laboratories – Key offerings
Exhibits123: Abbott Laboratories – Segment focus
Exhibits124: ALEVA NEUROTHERAPEUTICS SA – Overview
Exhibits125: ALEVA NEUROTHERAPEUTICS SA – Product / Service
Exhibits126: ALEVA NEUROTHERAPEUTICS SA – Key offerings
Exhibits127: Bayer AG – Overview
Exhibits128: Bayer AG – Business segments
Exhibits129: Bayer AG – Key news
Exhibits130: Bayer AG – Key offerings
Exhibits131: Bayer AG – Segment focus
Exhibits132: Boston Scientific Corp. – Overview
Exhibits133: Boston Scientific Corp. – Business segments
Exhibits134: Boston Scientific Corp. – Key news
Exhibits135: Boston Scientific Corp. – Key offerings
Exhibits136: Boston Scientific Corp. – Segment focus
Exhibits137: electroCore Inc. – Overview
Exhibits138: electroCore Inc. – Product / Service
Exhibits139: electroCore Inc. – Key offerings
Exhibits140: EndoStim Inc – Overview
Exhibits141: EndoStim Inc – Product / Service
Exhibits142: EndoStim Inc – Key offerings
Exhibits143: LABORIE MEDICAL TECHNOLOGIES CORP. – Overview
Exhibits144: LABORIE MEDICAL TECHNOLOGIES CORP. – Product / Service
Exhibits145: LABORIE MEDICAL TECHNOLOGIES CORP. – Key offerings
Exhibits146: LivaNova Plc – Overview
Exhibits147: LivaNova Plc – Business segments
Exhibits148: LivaNova Plc – Key offerings
Exhibits149: LivaNova Plc – Segment focus
Exhibits150: Medtronic Plc – Overview
Exhibits151: Medtronic Plc – Business segments
Exhibits152: Medtronic Plc – Key news
Exhibits153: Medtronic Plc – Key offerings
Exhibits154: Medtronic Plc – Segment focus
Exhibits155: NeuroMetrix Inc. – Overview
Exhibits156: NeuroMetrix Inc. – Product / Service
Exhibits157: NeuroMetrix Inc. – Key offerings
Exhibits158: NEURONETICS Inc. – Overview
Exhibits159: NEURONETICS Inc. – Product / Service
Exhibits160: NEURONETICS Inc. – Key offerings
Exhibits161: NeuroPace Inc. – Overview
Exhibits162: NeuroPace Inc. – Product / Service
Exhibits163: NeuroPace Inc. – Key offerings
Exhibits164: Nevro Corp. – Overview
Exhibits165: Nevro Corp. – Product / Service
Exhibits166: Nevro Corp. – Key offerings
Exhibits167: Soterix Medical Inc. – Overview
Exhibits168: Soterix Medical Inc. – Product / Service
Exhibits169: Soterix Medical Inc. – Key offerings
Exhibits170: Synapse Biomedical Inc. – Overview
Exhibits171: Synapse Biomedical Inc. – Product / Service
Exhibits172: Synapse Biomedical Inc. – Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR70270-23 )"神経刺激機器の世界市場2023~2027" (英文:Global Neurostimulation Devices Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。